Gary Marcus on AI.
Professor emeritus, cognitive scientist, New York University (United States). Summaries of on-the-record statements, each linked to the original recording or post.
On the record
“Keep an eye out, too, for the details of Anthropic’s S-1, and especially on how much they reveal (or not) about what has happened to demand in recent months, after the decline of tokenmaxxing and the increase in the popularity of low-cost alternative models.”
“literally left out Q3”
“Rumor has it that Anthropic is about to IPO.”
“In some ways, they couldn’t have picked a worse week.”
“We stand at a pivotal moment in history, and New York City has a chance to improve our chances, both for itself, and for the world.”
“What we need, above all else, is an FDA-like regulatory regime for AI, in which AI developers bring their software to independent review, much as drug manufacturers bring their new drugs to the FDA for a review.”
Statements
- Gary Marcus says Anthropic's S-1 filing omits key Q3 data
Gary Marcus, writing in his Substack newsletter, points out that Anthropic's draft S-1 filing appears to omit crucial data regarding Q3 performance, specifically concerning demand and the impact of alternative models.
- Gary Marcus Says Anthropic May Be Close to IPO
Gary Marcus reports a rumor that Anthropic is preparing for an Initial Public Offering (IPO), suggesting the timing might be challenging.
- Gary Marcus Argues for AI Regulation at NYC Council Hearing
Gary Marcus, a scientist and author, testified before the New York City Council, advocating for a regulatory regime for AI similar to the FDA for drugs. He argued that AI developers should be required to demonstrate that their products' benefits outweigh the risks before gaining market access.